{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:22:44Z","timestamp":1791883364556,"version":"4.3.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The postoperative outcomes of transcatheter aortic valve replacement (TAVR) with the new generation of self-expanding valves (SEV) and balloon-expandable valves (BEV) remain uncertain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a meta-analysis based on randomized controlled trials (RCTs) and propensity score-matched (PSM) studies to evaluate the performance of the new generation TAVR devices, with a focus on Edwards SAPIEN 3\/Ultra BEV, Medtronic Evolut R\/PRO SEV, and Boston ACURATE neo SEV. Our primary endpoints were mortality and complications at both 30\u00a0days and one year post-operation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 4 RCTs and 14 PSM studies were included. Our findings showed no significant difference between SEV and BEV regarding 30-day and 1-year mortality rates. ACURATE SEV required less permanent pacemaker implantation (PPI) at 30-day as compared to SAPIEN BEV, while Evolut SEV required a higher rate of PPI than SAPIEN BEV. The incidence of stroke, major or life-threatening bleeding (MLTB), major vascular complications (MVC), coronary artery obstruction (CAO) and acute kidney injury (AKI) did not differ significantly between the two groups. SEV had a larger effective orifice area (EOA) and lower mean transvalvular gradients (MPG) compared to BEV. However, there was an increased risk of paravalvular leakage (PVL) associated with SEV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In terms of 30-day mortality, stroke, bleeding, MVC, AKI, CAO, and one-year mortality, there was comparability between the two valve types following TAVR. SEV was associated with better hemodynamic outcomes, except for a higher incidence of PVL. Compared to SAPIEN BEV, ACURATE SEV had a lower risk of PPI at 30\u00a0days, while Evolut SEV was associated with a higher risk of PPI. These findings underscore the importance of personalized valve selection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03397-3","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T08:02:34Z","timestamp":1690790554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Comparison of outcomes of self-expanding versus balloon-expandable valves for transcatheter aortic valve replacement: a meta-analysis of randomized and propensity-matched studies"],"prefix":"10.1186","volume":"23","author":[{"given":"Baiqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guipeng","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"issue":"24","key":"3397_CR1","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1161\/01.CIR.0000047200.36165.B8","volume":"106","author":"A Cribier","year":"2002","unstructured":"Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006\u20138.","journal-title":"Circulation"},{"issue":"7","key":"3397_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561\u2013632.","journal-title":"Eur Heart J"},{"issue":"5","key":"3397_CR3","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72\u2013227.","journal-title":"Circulation"},{"issue":"11","key":"3397_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/17434440.2018.1536427","volume":"15","author":"OM Rotman","year":"2018","unstructured":"Rotman OM, Bianchi M, Ghosh RP, Kovarovic B, Bluestein D. Principles of TAVR valve design, modelling, and testing. Expert Rev Med Devices. 2018;15(11):771\u201391.","journal-title":"Expert Rev Med Devices"},{"issue":"8","key":"3397_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tcm.2021.10.002","volume":"32","author":"Z Tugaoen","year":"2022","unstructured":"Tugaoen Z, Nguyen P, Arora S, Vavalle J. The selection of transcatheter heart valves in transcatheter aortic valve replacement. Trends Cardiovasc Med. 2022;32(8):513\u201322.","journal-title":"Trends Cardiovasc Med"},{"issue":"15","key":"3397_CR6","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1001\/jama.2014.3316","volume":"311","author":"M Abdel-Wahab","year":"2014","unstructured":"Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311(15):1503\u201314.","journal-title":"JAMA"},{"issue":"4","key":"3397_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1161\/CIRCULATIONAHA.119.043785","volume":"141","author":"E Van Belle","year":"2020","unstructured":"Van Belle E, Vincent F, Labreuche J, et al. Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry. Circulation. 2020;141(4):243\u201359.","journal-title":"Circulation"},{"key":"3397_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"3397_CR9","first-page":"ED000142","volume":"10","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:ED000142.","journal-title":"Cochrane Database Syst Rev"},{"issue":"27","key":"3397_CR10","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta7270","volume":"7","author":"JJ Deeks","year":"2003","unstructured":"Deeks JJ, Dinnes J, D&#x27, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7(27):iii\u2013x 1\u2013173.","journal-title":"Health Technol Assess"},{"issue":"4","key":"3397_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/CIRCULATIONAHA.119.043971","volume":"141","author":"P Deharo","year":"2020","unstructured":"Deharo P, Bisson A, Herbert J, et al. Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis: Data From a Nationwide Analysis. Circulation. 2020;141(4):260\u20138.","journal-title":"Circulation"},{"issue":"12","key":"3397_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.4244\/EIJ-D-22-00164","volume":"18","author":"C Pellegrini","year":"2023","unstructured":"Pellegrini C, Rheude T, Renker M, et al. ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation. EuroIntervention. 2023;18(12):987\u201395.","journal-title":"EuroIntervention"},{"issue":"12","key":"3397_CR13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1161\/CIRCULATIONAHA.120.052251","volume":"143","author":"WK Kim","year":"2021","unstructured":"Kim WK, Walther T, Burgdorf C, et al. One-Year Outcomes of a Randomized Trial Comparing a Self-Expanding With a Balloon-Expandable Transcatheter Aortic Valve. Circulation. 2021;143(12):1267\u20139.","journal-title":"Circulation"},{"issue":"7","key":"3397_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008714","volume":"13","author":"A Mangieri","year":"2020","unstructured":"Mangieri A, Tchetch\u00e8 D, Kim WK, et al. Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights From the BEAT International Collaborative Registrys. Circ Cardiovasc Interv. 2020;13(7): e008714.","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"3397_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ccd.28524","volume":"95","author":"G Costa","year":"2020","unstructured":"Costa G, Buccheri S, Barbanti M, et al. Outcomes of three different new generation transcatheter aortic valve prostheses. Catheter Cardiovasc Interv. 2020;95(3):398\u2013407.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"3397_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s00392-018-1372-6","volume":"108","author":"A Finkelstein","year":"2019","unstructured":"Finkelstein A, Steinvil A, Rozenbaum Z, et al. Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registry. Clin Res Cardiol. 2019;108(4):430\u20137.","journal-title":"Clin Res Cardiol"},{"issue":"17","key":"3397_CR17","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.jacc.2021.03.007","volume":"77","author":"HJ Feistritzer","year":"2021","unstructured":"Feistritzer HJ, Kurz T, Stachel G, et al. Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2021;77(17):2204\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"3397_CR18","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1093\/eurheartj\/ehaa036","volume":"41","author":"H Thiele","year":"2020","unstructured":"Thiele H, Kurz T, Feistritzer HJ, et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J. 2020;41(20):1890\u20139.","journal-title":"Eur Heart J."},{"issue":"6","key":"3397_CR19","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/icvts\/ivx194","volume":"25","author":"A Schaefer","year":"2017","unstructured":"Schaefer A, Linder M, Seiffert M, et al. Comparison of latest generation transfemoral self-expandable and balloon-expandable transcatheter heart valves. Interact Cardiovasc Thorac Surg. 2017;25(6):905\u201311.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"10209","key":"3397_CR20","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/S0140-6736(19)32220-2","volume":"394","author":"J Lanz","year":"2019","unstructured":"Lanz J, Kim WK, Walther T, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. 2019;394(10209):1619\u201328.","journal-title":"Lancet"},{"issue":"10","key":"3397_CR21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.4244\/EIJ-D-18-01120","volume":"15","author":"S Barth","year":"2019","unstructured":"Barth S, Reents W, Zacher M, et al. Multicentre propensity-matched comparison of transcatheter aortic valve implantation using the ACURATE TA\/neo self-expanding versus the SAPIEN 3 balloon-expandable prosthesis. EuroIntervention. 2019;15(10):884\u201391.","journal-title":"EuroIntervention"},{"key":"3397_CR22","doi-asserted-by":"crossref","unstructured":"Mauri V, Kim WK, Abumayyaleh M, et al. Short-Term Outcome and Hemodynamic Performance of Next-Generation Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valves in Patients With Small Aortic Annulus: A Multicenter Propensity-Matched Comparison. Circ Cardiovasc Interv. 2017;10(10):e005013.","DOI":"10.1161\/CIRCINTERVENTIONS.117.005013"},{"issue":"20","key":"3397_CR23","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/j.jcin.2017.06.026","volume":"10","author":"O Husser","year":"2017","unstructured":"Husser O, Kim WK, Pellegrini C, et al. Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves. JACC Cardiovasc Interv. 2017;10(20):2078\u201387.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"3397_CR24","doi-asserted-by":"publisher","first-page":"E875","DOI":"10.1002\/ccd.29259","volume":"97","author":"H Hase","year":"2021","unstructured":"Hase H, Yoshijima N, Yanagisawa R, et al. Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry. Catheter Cardiovasc Interv. 2021;97(6):E875\u201386.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"23","key":"3397_CR25","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/j.jcin.2022.08.057","volume":"15","author":"G Costa","year":"2022","unstructured":"Costa G, Saia F, Pilgrim T, et al. Transcatheter Aortic Valve Replacement With the Latest-Iteration Self-Expanding or Balloon-Expandable Valves: The Multicenter OPERA-TAVI Registry. JACC Cardiovasc Interv. 2022;15(23):2398\u2013407.","journal-title":"JACC Cardiovasc Interv"},{"key":"3397_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijcard.2022.03.043","volume":"357","author":"T Rheude","year":"2022","unstructured":"Rheude T, Pellegrini C, Allali A, et al. Multicenter comparison of latest-generation balloon-expandable versus self-expanding transcatheter heart valves: Ultra versus Evolut. Int J Cardiol. 2022;357:115\u201320.","journal-title":"Int J Cardiol"},{"key":"3397_CR27","doi-asserted-by":"crossref","unstructured":"Potratz M, Mohemed K, Omran H, et al. Hemodynamic Performance of Two Current-Generation Transcatheter Heart Valve Prostheses in Severely Calcified Aortic Valve Stenosis. J Clin Med. 2022;11(15):4570.","DOI":"10.3390\/jcm11154570"},{"key":"3397_CR28","doi-asserted-by":"crossref","unstructured":"van Nieuwkerk AC, Santos RB, Andraka L, et al. Balloon-Expandable versus Self-Expandable Valves in Transcatheter Aortic Valve Implantation: Complications and Outcomes from a Large International Patient Cohort. J Clin Med. 2021;10(17):4005.","DOI":"10.3390\/jcm10174005"},{"issue":"5","key":"3397_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/eurheartj\/ehy805","volume":"40","author":"W Vlastra","year":"2019","unstructured":"Vlastra W, Chandrasekhar J, Mu\u00f1oz-Garcia AJ, et al. Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration. Eur Heart J. 2019;40(5):456\u201365.","journal-title":"Eur Heart J."},{"issue":"6","key":"3397_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4244\/EIJV5I6A111","volume":"5","author":"NM Van Mieghem","year":"2010","unstructured":"Van Mieghem NM, Nuis RJ, Piazza N, et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention. 2010;5(6):673\u20139.","journal-title":"EuroIntervention"},{"issue":"8","key":"3397_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nrcardio.2012.58","volume":"9","author":"RM van der Boon","year":"2012","unstructured":"van der Boon RM, Nuis RJ, Van Mieghem NM, et al. New conduction abnormalities after TAVI\u2013frequency and causes. Nat Rev Cardiol. 2012;9(8):454\u201363.","journal-title":"Nat Rev Cardiol"},{"issue":"20","key":"3397_CR32","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.jacc.2010.06.035","volume":"56","author":"MA Sherif","year":"2010","unstructured":"Sherif MA, Abdel-Wahab M, St\u00f6cker B, et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. J Am Coll Cardiol. 2010;56(20):1623\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3397_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4244\/EIJV8I1A20","volume":"8","author":"H Eggebrecht","year":"2012","unstructured":"Eggebrecht H, Schmermund A, Voigtl\u00e4nder T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8(1):129\u201338.","journal-title":"EuroIntervention"},{"issue":"17","key":"3397_CR34","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","volume":"374","author":"MB Leon","year":"2016","unstructured":"Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374(17):1609\u201320.","journal-title":"N Engl J Med"},{"issue":"13","key":"3397_CR35","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1161\/CIRCULATIONAHA.113.002677","volume":"129","author":"E Van Belle","year":"2014","unstructured":"Van Belle E, Juthier F, Susen S, et al. Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry. Circulation. 2014;129(13):1415\u201327.","journal-title":"Circulation"},{"key":"3397_CR36","doi-asserted-by":"crossref","unstructured":"Deharo P, Leroux L, Theron A, et al. Long-Term Prognosis Value of Paravalvular Leak and Patient-Prosthesis. Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry. J Clin Med. 2022;11(20):6117.","DOI":"10.3390\/jcm11206117"},{"issue":"5","key":"3397_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s00392-020-01775-x","volume":"110","author":"PC Seppelt","year":"2021","unstructured":"Seppelt PC, Mas-Peiro S, De Rosa R, Dimitriasis Z, Zeiher AM, Vasa-Nicotera M. Thirty-day incidence of. stroke after transfemoral transcatheter aortic valve implantation: meta-analysis and mixt-treatment comparison of self-expandable versus balloon-expandable valve prostheses. Clin Res Cardiol. 2021;110(5):640\u20138.","journal-title":"Clin Res Cardiol."},{"issue":"7","key":"3397_CR38","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jacc.2016.05.065","volume":"68","author":"V Auffret","year":"2016","unstructured":"Auffret V, Regueiro A, Del Trigo M, et al. Predictors of Early Cerebrovascular Events in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016;68(7):673\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3397_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jcin.2012.02.010","volume":"5","author":"L Nombela-Franco","year":"2012","unstructured":"Nombela-Franco L, Rod\u00e9s-Cabau J, DeLarochelli\u00e8re R, et al. Predictive factors, efficacy, and safety of. balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5(5):499\u2013512.","journal-title":"JACC Cardiovasc Interv."},{"issue":"2","key":"3397_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jcin.2022.10.020","volume":"16","author":"PM Grossman","year":"2023","unstructured":"Grossman PM, Sukul D, Lall SC, et al. The Relationship Between Hospital Stroke Center Designation and. TVT Reported Stroke: The Michigan TAVR Experience. JACC Cardiovasc Interv. 2023;16(2):168\u201376.","journal-title":"JACC Cardiovasc Interv."},{"issue":"14","key":"3397_CR41","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMoa2204961","volume":"387","author":"SR Kapadia","year":"2022","unstructured":"Kapadia SR, Makkar R, Leon M, Abdel-Wahab M, Waggoner T, Massberg S, et al. Cerebral Embolic. Protection during Transcatheter Aortic-Valve Replacement. N Engl J Med. 2022;387(14):1253\u201363.","journal-title":"N Engl J Med."},{"issue":"1","key":"3397_CR42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12872-023-03338-0","volume":"23","author":"M Wolfrum","year":"2023","unstructured":"Wolfrum M, Handerer IJ, Moccetti F, Schmeisser A, Braun-Dullaeus RC, Toggweiler S. Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device. BMC Cardiovasc Disord. 2023;23(1):306.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"3397_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/ejcts\/ezaa053","volume":"58","author":"J Haunschild","year":"2020","unstructured":"Haunschild J, Misfeld M, Schroeter T, et al. Prevalence of permanent pacemaker implantation after conventional aortic valve replacement-a propensity-matched analysis in patients with a bicuspid or tricuspid aortic valve: a benchmark for transcatheter aortic valve replacement. Eur J Cardiothorac Surg. 2020;58(1):130\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"21","key":"3397_CR44","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/j.jcin.2016.07.026","volume":"9","author":"OO Fadahunsi","year":"2016","unstructured":"Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons\/American College of Cardiology TVT Registry. JACC Cardiovasc Interv. 2016;9(21):2189\u201399.","journal-title":"JACC Cardiovasc Interv."},{"issue":"4","key":"3397_CR45","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.amjcard.2013.04.026","volume":"112","author":"I Franzoni","year":"2013","unstructured":"Franzoni I, Latib A, Maisano F, et al. Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol. 2013;112(4):554\u20139.","journal-title":"Am J Cardiol"},{"issue":"1","key":"3397_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2018-000972","volume":"6","author":"JT Tretter","year":"2019","unstructured":"Tretter JT, Mori S, Anderson RH, et al. Anatomical predictors of conduction damage after transcatheter implantation of the aortic valve. Open Heart. 2019;6(1): e000972.","journal-title":"Open Heart"},{"key":"3397_CR47","doi-asserted-by":"crossref","unstructured":"Abdelfattah OM, Abushouk A, Elgendy IY, Elbadawi A, Khalid U, G\u00e9n\u00e9reux P, et al. Impact of Implantation Depth on Transcatheter Aortic Valve Replacement Outcomes: A Meta-Analysis. J Soc Cardiovasc Angiography Interv. 2022;1(6):100450.","DOI":"10.1016\/j.jscai.2022.100450"},{"issue":"1","key":"3397_CR48","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.120.009407","volume":"14","author":"Y Sammour","year":"2021","unstructured":"Sammour Y, Banerjee K, Kumar A, Lak H, Chawla S, Incognito C, et al. Systematic Approach to High Implantation of SAPIEN-3 Valve Achieves a Lower Rate of Conduction Abnormalities Including Pacemaker Implantation. Circ Cardiovasc Interv. 2021;14(1): e009407.","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"3397_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.118.007756","volume":"12","author":"N Moriyama","year":"2019","unstructured":"Moriyama N, Vento A, Laine M. Safety of Next-Day Discharge After Transfemoral Transcatheter Aortic Valve Replacement With a Self-Expandable Versus Balloon-Expandable Valve Prosthesis. Circ Cardiovasc Interv. 2019;12(6): e007756.","journal-title":"Circ Cardiovasc Interv"},{"key":"3397_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijcard.2022.09.035","volume":"371","author":"TT Lerman","year":"2023","unstructured":"Lerman TT, Levi A, Kornowski R. Meta-analysis of short- and long-term clinical outcomes of the self-expanding Evolut R\/pro valve versus the balloon-expandable Sapien 3 valve for transcatheter aortic valve implantation. Int J Cardiol. 2023;371:100\u20138.","journal-title":"Int J Cardiol"},{"issue":"3","key":"3397_CR51","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jcin.2016.11.025","volume":"10","author":"SS Kalra","year":"2017","unstructured":"Kalra SS, Firoozi S, Yeh J, et al. Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters\u2019 Registry. JACC Cardiovasc Interv. 2017;10(3):276\u201382.","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"3397_CR52","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jcin.2015.08.014","volume":"8","author":"O Husser","year":"2015","unstructured":"Husser O, Pellegrini C, Kessler T, et al. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience. JACC Cardiovasc Interv. 2015;8(14):1809\u201316.","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"3397_CR53","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jcin.2013.05.004","volume":"6","author":"S Toggweiler","year":"2013","unstructured":"Toggweiler S, Leipsic J, Binder RK, et al. Management of vascular access in transcatheter aortic valve replacement: part 2: Vascular complications. JACC Cardiovasc Interv. 2013;6(8):767\u201376.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"3397_CR54","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jcin.2020.01.216","volume":"13","author":"T Ochiai","year":"2020","unstructured":"Ochiai T, Chakravarty T, Yoon SH, Kaewkes D, Flint N, Patel V, et al. Coronary Access After TAVR. JACC Cardiovasc Interv. 2020;13(6):693\u2013705.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"3397_CR55","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jcin.2020.01.202","volume":"13","author":"T Rogers","year":"2020","unstructured":"Rogers T, Greenspun BC, Weissman G, Torguson R, Craig P, Shults C, et al. Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients. JACC Cardiovasc Interv. 2020;13(6):726\u201335.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"3397_CR56","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jcin.2020.01.227","volume":"13","author":"F Mercanti","year":"2020","unstructured":"Mercanti F, Rosseel L, Neylon A, Bagur R, Sinning JM, Nickenig G, et al. Chimney Stenting for Coronary Occlusion During TAVR: Insights From the Chimney Registry. JACC Cardiovasc Interv. 2020;13(6):751\u201361.","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"3397_CR57","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.jcin.2021.05.037","volume":"14","author":"M Kitamura","year":"2021","unstructured":"Kitamura M, Wilde J, Gohmann R, Majunke N, Gutberlet M, Shibata M, et al. Commissural Alignment of the ACURATE neo Valve in Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2021;14(15):1740\u20132.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"3397_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011045","volume":"15","author":"G Tarantini","year":"2022","unstructured":"Tarantini G, Nai Fovino L, Scotti A, Massussi M, Cardaioli F, Rodino G, et al. Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study. Circ Cardiovasc Interv. 2022;15(2): e011045.","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"3397_CR59","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.amjcard.2012.11.063","volume":"111","author":"L Nombela-Franco","year":"2013","unstructured":"Nombela-Franco L, Ruel M, Radhakrishnan S, et al. Comparison of hemodynamic performance of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol. 2013;111(7):1026\u201333.","journal-title":"Am J Cardiol"},{"issue":"10","key":"3397_CR60","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.amjcard.2019.08.014","volume":"124","author":"W Mosleh","year":"2019","unstructured":"Mosleh W, Amer MR, Joshi S, et al. Comparative Outcomes of Balloon-Expandable S3 Versus Self-Expanding Evolut Bioprostheses for Transcatheter Aortic Valve Implantation. Am J Cardiol. 2019;124(10):1621\u20139.","journal-title":"Am J Cardiol"},{"issue":"9","key":"3397_CR61","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.recesp.2017.10.032","volume":"71","author":"E Enr\u00edquez-Rodr\u00edguez","year":"2018","unstructured":"Enr\u00edquez-Rodr\u00edguez E, Amat-Santos IJ, Jim\u00e9nez-Quevedo P, et al. Comparison of the Hemodynamic Performance of the Balloon-expandable SAPIEN 3 Versus Self-expandable Evolut R Transcatheter Valve: A Case-matched Study. Rev Esp Cardiol (Engl Ed). 2018;71(9):735\u201342.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"5","key":"3397_CR62","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/ccd.27977","volume":"93","author":"M Abdelghani","year":"2019","unstructured":"Abdelghani M, Allali A, Kaur J, et al. Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2019;93(5):971\u20139.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"3397_CR63","doi-asserted-by":"publisher","first-page":"15014","DOI":"10.1038\/s41598-017-15396-4","volume":"7","author":"YB Liao","year":"2017","unstructured":"Liao YB, Li YJ, Jun-Li L, et al. Incidence, Predictors and Outcome of Prosthesis-Patient Mismatch after Transcatheter Aortic Valve Replacement: a Systematic Review and Meta-analysis. Sci Rep. 2017;7(1):15014.","journal-title":"Sci Rep"},{"issue":"21","key":"3397_CR64","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jcin.2019.07.027","volume":"12","author":"T Okuno","year":"2019","unstructured":"Okuno T, Khan F, Asami M, et al. Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement With Supra-Annular and Intra-Annular Prostheses. JACC Cardiovasc Interv. 2019;12(21):2173\u201382.","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"3397_CR65","volume":"13","author":"S Vallabhaneni","year":"2021","unstructured":"Vallabhaneni S, Matka M, Modi V, et al. Prevalence and Significance of Patient Prosthesis Mismatch Following Edwards SAPIEN XT and SAPIEN 3 Transcatheter Aortic Valve Replacement. Cureus. 2021;13(9): e18044.","journal-title":"Cureus"},{"issue":"1","key":"3397_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4244\/EIJ-D-17-00603","volume":"14","author":"MA Deutsch","year":"2018","unstructured":"Deutsch MA, Erlebach M, Burri M, et al. Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices. EuroIntervention. 2018;14(1):41\u20139.","journal-title":"EuroIntervention"},{"key":"3397_CR67","doi-asserted-by":"publisher","first-page":"8249497","DOI":"10.1155\/2020\/8249497","volume":"2020","author":"A Hagar","year":"2020","unstructured":"Hagar A, Li Y, Wei X, et al. Incidence, Predictors, and Outcome of Paravalvular Leak after Transcatheter Aortic Valve Implantation. J Interv Cardiol. 2020;2020:8249497.","journal-title":"J Interv Cardiol"},{"issue":"15","key":"3397_CR68","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jacc.2013.01.047","volume":"61","author":"G Athappan","year":"2013","unstructured":"Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585\u201395.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3397_CR69","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2459\/JCM.0000000000000757","volume":"20","author":"M Kowalewski","year":"2019","unstructured":"Kowalewski M, Gozdek M, Raffa GM, et al. Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach. J Cardiovasc Med (Hagerstown). 2019;20(4):226\u201336.","journal-title":"J Cardiovasc Med (Hagerstown)."},{"key":"3397_CR70","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijcard.2016.06.159","volume":"220","author":"T Ando","year":"2016","unstructured":"Ando T, Briasoulis A, Holmes AA, Taub CC, Takagi H, Afonso L. Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: A meta-analysis. Int J Cardiol. 2016;220:472\u20138.","journal-title":"Int J Cardiol"},{"issue":"12","key":"3397_CR71","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jcin.2022.05.004","volume":"15","author":"G Witberg","year":"2022","unstructured":"Witberg G, Landes U, Talmor-Barkan Y, et al. Center Valve Preference and Outcomes of Transcatheter Aortic Valve Replacement: Insights From the AMTRAC Registry. JACC Cardiovasc Interv. 2022;15(12):1266\u201374.","journal-title":"JACC Cardiovasc Interv"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03397-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03397-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03397-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T08:03:01Z","timestamp":1690790581000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03397-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3397"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03397-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"8 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}